New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2014
16:19 EDTM, RHHBY, GSK, SNY, ITMN, KING, SEAS, EBAY, AMZN, CSIQOn The Fly: Closing Wrap
Stocks on Wall Street began the day in positive territory despite weaker than expected retail sales figures for July. Oil hit a new 13 month low during the session, suggesting to investors that concerns about the flow of oil from the Middle East are muted despite the turmoil in Iraq and Israel. The market found its level about an hour and a half into trading and the averages moved in a narrow range for the remainder of the session, but the Nasdaq's drift higher managed to add 1% to the index by the time trading closed. ECONOMIC EVENTS: In the U.S., retail sales were flat in July, versus an expected 0.2% increase. If auto and gasoline data is removed, the core reading showed an increase of 0.1%, versus the expected 0.4% rise. Business inventories grew 0.4% in June, which was in-line with expectations. In Asia, a measure of new credit in China came in at $44.3B in July, marking its lowest monthly total since October 2008. China's industrial production grew 9.0% year-over-year in the month, versus expectations for 9.2% growth. Japan's second quarter GDP fell an annualized 6.8%, which was slightly better than the expectation for a 7% decline. COMPANY NEWS: Macy's (M) declined $3.29, or 5.51%, to $56.47 after the department store operator's second quarter sales and profits missed expectations. Macy's also lowered its fiscal year same-store sales growth forecast to 1.5%-2% from its previous 2.5%-3% view, but said it still expects FY14 earnings per share of $4.40-$4.50... Amazon.com (AMZN) advanced $6.96, or 2.18%, to $326.28 after the company launched "Amazon Local Register," a credit-card device and mobile app to help small business owners accept payments that will go head-to-head with competing systems from Square and eBay's (EBAY) PayPal unit. Additionally, research firm ChannelAdvisor reported that Amazon's July same-store-sales grew 40.4%, an increase compared to June's 34.4% growth rate. Meanwhile, the firm estimated eBay's July same-store-sales grew 9.7%, which was down from June’s 12.3% rate and below the e-commerce growth rate, and its shares slipped 49c, or 0.92%, to $52.94. MAJOR MOVERS: Among the notable gainers was Canadian Solar (CSIQ), which rose $6.06, or 24.27%, to $30.13 after the company reported better than expected second quarter results. Also higher was InterMune (ITMN), which jumped $6.57, or 14.44%, to $52.06 after Bloomberg said the company is working with its financial advisers to evaluate takeover bids it has received from Sanofi (SNY), Roche (RHHBY), GlaxoSmithKline (GSK) and Actelion (ALIOF). Among the noteworthy losers was theme park operator SeaWorld (SEAS), which dove $9.25, or 32.86%, to $18.90 after negative media attention contributed to lower than expected second quarter attendance and drove its earnings per share and revenue to miss expectations. Also lower were shares of social video game maker King Digital (KING), which was downgraded by at least five Street research firms and dropped $4.21, or 23.13%, to $13.99 after its quarterly revenue missed expectations and the company lowered its outlook for its fiscal 2014 growth rates. INDEXES: The Dow rose 91.26, or 0.55%, to 16,651.80, the Nasdaq gained 44.88, or 1.02%, to 4,434.13, and the S&P 500 added 12.97, or 0.67%, to 1,946.72.
News For M;AMZN;EBAY;SEAS;KING;ITMN;SNY;GSK;RHHBY;CSIQ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
October 20, 2014
07:22 EDTCSIQSolar Energy Trade Shows to hold a conference
Subscribe for More Information
07:19 EDTCSIQJPMorgan says recent sell-off in solar space unjustified
Subscribe for More Information
07:19 EDTGSK, RHHBY, SNYIBC Life Sciences to hold a conference
Subscribe for More Information
07:11 EDTRHHBYAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
07:10 EDTRHHBY, SNYAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
07:06 EDTRHHBYNewLink announces worldwide license agreement for NLG919 development
Subscribe for More Information
07:04 EDTRHHBYRoche approval would be positive for TESARO, says Jefferies
Subscribe for More Information
07:02 EDTSNYRegeneron Sanofi begins dosing in Phase 3 study of dupilumab
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis, or AD, that is not adequately controlled with topical AD medications. LIBERTY AD CHRONOS, the first trial in the Phase 3 clinical program for dupilumab, is a randomized, double-blind, placebo-controlled, multi-national study with the primary objective of demonstrating the efficacy of dupilumab in adults with moderate to severe AD when administered concomitantly with topical corticosteroids through 16 weeks.
06:01 EDTEBAYStocks with implied volatility below IV index mean; EBAY NFLX
Stocks with implied volatility below IV index mean; eBay (EBAY) 27, Netflix (NFLX) 40 according to iVolatility.
05:59 EDTAMZNStocks with implied volatility above IV index mean; DISH AMZN
Subscribe for More Information
05:27 EDTEBAYeBay announces resignation of Marc Andreessen from board
Subscribe for More Information
October 17, 2014
16:55 EDTEBAYStocks end volatile week lower amid oil price plunge
Subscribe for More Information
16:01 EDTAMZNOptions Update; October 17, 2014
iPath S&P 500 VIX Short-Term Futures down 1.75 to 38.58 Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX GILD CLF PBR according to Track Data.
14:50 EDTGSKBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
12:11 EDTEBAYeBay announces launch of domestic selling in Russia
Subscribe for More Information
11:17 EDTGSKGSK says Ebola vaccine too late for current epidemic, BBC reports
Subscribe for More Information
09:22 EDTAMZNAmazon.com volatility elevated into Q3 and outlook
Subscribe for More Information
09:06 EDTSNYAmgen files patent infringement lawsuit against Sanofi, Regeneron
Amgen (AMGN) announced that it filed a lawsuit in the United States District Court of Delaware against Sanofi (SNY), Aventisub, formerly doing business as Aventis Pharmaceuticals, and Regeneron Pharmaceuticals (REGN) for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741. These patents, which are owned by Amgen, describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9, or PCSK9. By its complaint, Amgen seeks an injunction to prevent the infringing manufacture, use and sale of Sanofi and Regeneron's alirocumab, a monoclonal antibody targeting PCSK9. Sanofi and Regeneron recently announced that they have completed Phase 3 clinical trials on alirocumab and intend to pursue regulatory approval to market alirocumab in the U.S. Amgen previously announced submission of a Biologics License Application to the FDA for evolocumab, its own investigational human monoclonal antibody to PCSK9, for the treatment of high cholesterol, on Aug. 28.
06:22 EDTAMZNStocks with implied volatility above IV index mean; GT AMZN
Subscribe for More Information
06:03 EDTAMZNAmazon Fresh now available in select areas in New York
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use